1.Lourida I, Soni M, Thompson-Coon J, et al. (2013) Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 24, 479–489.
2.Singh B, Parsaik AK, Mielke MM, et al. (2014) Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 39, 271–282.
3.Van de Rest O, Berendsen AA, Haveman-Nies A, et al. (2015) Dietary patterns, cognitive decline, and dementia: a systematic review. Adv Nutr 6, 154–168.
4.Morris MC (2012) Nutritional determinants of cognitive aging and dementia. Proc Nutr Soc 71, 1–13.
5.Gomez-Pinilla F (2008) Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9, 568–578.
6.Morris MC & Tangney CC (2014) Dietary fat composition and dementia risk. Neurobiol Aging 35, Suppl. 2, S59–S64.
7.Kennard JA & Harrison FE (2014) Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice. Behav Brain Res 264, 34–42.
8.Kim SJ, Son TG, Park HR, et al. (2008) Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 283, 14497–14505.
9.Frautschy SA, Hu W, Kim P, et al. (2001) Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiol Aging 22, 993–1005.
10.Green KN, Martinez-Coria H, Khashwji H, et al. (2007) Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 27, 4385–4395.
11.Lim GP, Chu T, Yang F, et al. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, 8370–8377.
12.Wang J, Ho L, Zhao W, et al. (2008) Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. J Neurosci 28, 6388–6392.
13.Fahnestock M, Marchese M, Head E, et al. (2012) BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. Neurobiol Aging 33, 546–554.
14.Milgram NW, Zicker SC, Head E, et al. (2002) Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging 23, 737–745.
15.Pop V, Head E, Hill M-A, et al. (2010) Synergistic effects of long-term antioxidant diet and behavioral enrichment on β-amyloid load and non-amyloidogenic processing in aged canines. J Neurosci 30, 9831–9839.
16.Aisen PS, Schneider LS, Sano M, et al. (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300, 1774–1783.
17.Dangour AD, Allen E, Elbourne D, et al. (2010) Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people : a randomized, double-blind, controlled trial. Am J Clin Nutr 91, 1725–1732.
18.Ford AH, Flicker L, Alfonso H, et al. (2010) Vitamins B12, B6, and folic acid for cognition in older men. Neurology 75, 1540–1547.
19.Kwok T, Lee J, Law CB, et al. (2011) A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin Nutr 30, 297–302.
20.McMahon JA, Green TJ, Skeaff CM, et al. (2006) A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 354, 2764–2772.
21.Petersen RC, Thomas RG, Grundman M, et al. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352, 2379–2788.
22.Quinn JF, Raman R, Thomas RG, et al. (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304, 1903–1911.
23.Sun Y, Lu C-J, Chien K-L, et al. (2007) Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer’s disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 29, 2204–2214.
24.Van de Rest O, Geleijnse JM, Kok FJ, et al. (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71, 430–438.
25.Kang JH, Cook N, Manson J, et al. (2006) A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 166, 2462–2468.
26.Benton D (2010) Neurodevelopment and neurodegeneration: are there critical stages for nutritional intervention? Nutr Rev 68, Suppl. 1, S6–S10.
27.De Jager CA & Kovatcheva A (2010) Summary and discussion: methodologies to assess long-term effects of nutrition on brain function. Nutr Rev 68, Suppl. 1, S53–S58.
28.Otaegui-Arrazola A, Amiano P, Elbusto A, et al. (2014) Diet, cognition, and Alzheimer’s disease: food for thought. Eur J Nutr 53, 1–23.
29.Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, et al. (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind study. Arch Neurol 63, 1402–1408.
30.Sperling RA, Aisen PS, Beckett L, et al. (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7, 280–292.
31.Jack CR, Knopman DS, Jagust WJ, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9, 119–128.
32.Perneczky R, Wagenpfeil S, Komossa K, et al. (2006) Mapping scores onto stages: Mini-Mental State Examination and clinical dementia rating. Am J Geriatr Psychiatry 14, 139–144.
33.Aisen PS, Cummings J & Schneider LS (2012) Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med 2, a006395.
34.De Jager CA, Oulhaj A, Jacoby R, et al. (2012) Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry 27, 592–600.
35.Dufouil C, Alpérovitch A, Ducros V, et al. (2003) Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 53, 214–221.
36.Seshadri S, Beiser A, Selhub J, et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346, 476–483.
37.Chiu C-C, Su K-P, Cheng T-C, et al. (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32, 1538–1544.
38.Kotani S, Sakaguchi E, Warashina S, et al. (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56, 159–164.
39.Lee LK, Shahar S, Chin A-V, et al. (2013) Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 225, 605–612.
40.Van Uffelen JGZ, Chinapaw MJM, van Mechelen W, et al. (2008) Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br J Sports Med 42, 344–351.
41.Eussen SJ, de Groot LC, Joosten LW, et al. (2006) Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 84, 361–370.
42.Kwok T, Lee J, Lam L, et al. (2008) Vitamin B12 supplementation did not improve cognition but reduced delirium in demented patients with vitamin B12 deficiency. Arch Gerontol Geriatr 46, 273–282.
43.Morris MC, Evans DA, Schneider JA, et al. (2006) Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer’s disease. J Alzheimers Dis 9, 435–443.
44.Engelhart MJ, Geerlings MI, Ruitenberg A, et al. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287, 3223–3229.
45.Morris MC, Evans DA, Bienias JL, et al. (2002) Vitamin E and cognitive decline in older persons. Arch Neurol 59, 1125–1132.
46.Park DC, Lautenschlager G, Hedden T, et al. (2002) Models of visuospatial and verbal memory across the adult life span. Psychol Aging 17, 299–320.
47.Grodstein F, Kang JH, Glynn RJ, et al. (2007) A randomized trial of β carotene supplementation and cognitive function in men: the Physicians’ Health Study II. 167, 2184–2190.
48.Yurko-Mauro K, McCarthy D, Rom D, et al. (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6, 456–464.
49.Durga J, van Boxtel MPJ, Schouten EG, et al. (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369, 208–216.
50.Clarke R, Bennett D, Parish S, et al. (2014) Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000. Am J Clin Nutr 100, 657–666.
51.van der Zwaluw NL, Dhonukshe-Rutten RA, Van Wijngaarden JP, et al. (2014) Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology 83, 2158–2166.
52.Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, et al. (2011) Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr 94, 278–286.
53.Macready AL, Butler LT, Kennedy OB, et al. (2010) Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies. Nutr Res Rev 23, 200–229.
54.Jagust W (2013) Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron 77, 219–234.
55.Raz N, Ghisletta P, Rodrigue KM, et al. (2010) Trajectories of brain aging in middle-aged and older adults: regional and individual differences. NeuroImage 51, 501–511.
56.Yankner BA, Lu T & Loerch P (2008) The aging brain. Annu Rev Pathol 3, 41–66.
57.Nyberg L, Maitland SB, Rönnlund M, et al. (2003) Selective adult age differences in an age-invariant multifactor model of declarative memory. Psychol Aging 18, 149–160.
58.Fjell AM, Westlye LT, Grydeland H, et al. (2013) Critical ages in the life course of the adult brain: nonlinear subcortical aging. Neurobiol Aging 34, 2239–2247.
59.Morrison JH & Baxter MG (2012) The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 13, 240–250.
60.Bennett DA, Wilson RS, Boyle PA, et al. (2012) Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol 72, 599–609.
61.Braak H, Thal DR, Ghebremedhin E, et al. (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70, 960–969.
62.Eichenbaum H & Cohen NJ (2001) From Conditioning to Conscious Recollection: Multiple Memory Systems in the Brain. New York: Oxford University Press.
63.Cohen N & Eichenbaum HJ (1993) Memory, Amnesia and the Hippocampal System. Cambridge, MA: MIT Press.
64.Konkel A & Cohen NJ (2009) Relational memory and the hippocampus: representations and methods. Front Neurosci 3, 166–174.
65.Naveh-Benjamin M (2000) Adult age differences in memory performance: tests of an associative deficit hypothesis. J Exp Psychol Learn Mem Cogn 26, 1170–1187.
66.Cabeza R, Ciaramelli E, Olson IR, et al. (2008) The parietal cortex and episodic memory: an attentional account. Nat Rev Neurosci 9, 613–625.
67.Simons JS & Spiers HJ (2003) Prefrontal and medial temporal lobe interactions in long-term memory. Nat Rev Neurosci 4, 637–648.
68.Wagner AD, Shannon BJ, Kahn I, et al. (2005) Parietal lobe contributions to episodic memory retrieval. Trends Cogn Sci 9, 445–453.
69.Casadesus G, Shukitt-Hale B, Stellwagen HM, et al. (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7, 309–316.
70.Van Praag H, Lucero MJ, Yeo GW, et al. (2007) Plant-derived flavanol (–)epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 27, 5869–5878.
71.He C, Qu X, Cui L, et al. (2009) Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci U S A 106, 11370–11375.
72.Petursdottir AL, Farr SA, Morley JE, et al. (2008) Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 63, 1153–1160.
73.Wang J, Santa-Maria I, Ho L, et al. (2010) Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer’s disease. J Alzheimers Dis 22, 653–661.
74.Lim GP, Calon F, Morihara T, et al. (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25, 3032–3040.
75.Gazzaley A & Nobre AC (2012) Top-down modulation: bridging selective attention and working memory. Trends Cogn Sci 16, 129–135.
76.Kane MJ & Engle RW (2002) The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon Bull Rev 9, 637–671.
77.Barbey AK, Colom R, Solomon J, et al. (2012) An integrative architecture for general intelligence and executive function revealed by lesion mapping. Brain 135, 1154–1164.
78.Buckner R (2004) Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 44, 195–208.
79.Erickson K, Suever B, Prakash R, et al. (2008) Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study. Brain Res 1553, 20–26.
80.Rodrigue KM, Kennedy KM, Devous MD, et al. (2012) β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology 78, 387–395.
81.Sperling RA, Laviolette PS, O’Keefe K, et al. (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63, 178–188.
82.Kennedy KM, Rodrigue KM, Devous MD, et al. (2012) Effects of β-amyloid accumulation on neural function during encoding across the adult lifespan. NeuroImage 62, 1–8.
83.Rentz DM, Amariglio RE, Becker JA, et al. (2011) Face–name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia 49, 2776–2783.
84.Bayer-Carter JL, Green PS, Montine TJ, et al. (2011) Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol 68, 743–752.
85.Salthouse TA (2009) When does age-related cognitive decline begin? Neurobiol Aging 30, 507–514.
86.Salthouse TA (1996) The processing-speed theory of adult age differences in cognition. Psychol Rev 103, 403–428.
87.Salthouse TA (2010) Selective review of cognitive aging. J Int Neuropsychol Soc 16, 754–760.
88.Borghesani PR, Madhyastha TM, Aylward EH, et al. (2013) The association between higher order abilities, processing speed, and age are variably mediated by white matter integrity during typical aging. Neuropsychologia 51, 1435–1444.
89.Wen W, Zhu W, He Y, et al. (2011) Discrete neuroanatomical networks are associated with specific cognitive abilities in old age. J Neurosci 31, 1204–1212.
90.Wen W & Sachdev P (2004) The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. NeuroImage 22, 144–154.
91.Bowman GL, Silbert LC, Howieson D, et al. (2012) Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 78, 241–249.
92.Scarmeas N, Luchsinger J, Stern Y, et al. (2011) Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol 69, 257–268.
93.Lezak MD, Howieson DB, Loring DW, et al. (2004) Neuropsychological Assessment, 4th ed. New York: Oxford University Press.
94.Weintraub S, Wicklund AH & Salmon DP (2012) The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2, a006171.
95.Jessen F, Wiese B, Bachmann C, et al. (2010) Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry 67, 414–422.
96.Hannula DE, Tranel D & Cohen NJ (2006) The long and the short of it: relational memory impairments in amnesia, even at short lags. J Neurosci 26, 8352–8359.
97.Hannula DE, Ryan JD, Tranel D, et al. (2007) Rapid onset relational memory effects are evident in eye movement behavior, but not in hippocampal amnesia. J Cogn Neurosci 19, 1690–1705.
98.Konkel A, Warren DE, Duff MC, et al. (2008) Hippocampal amnesia impairs all manner of relational memory. Front Hum Neurosci 2, 15.
99.Monti JM, Cooke GE, Watson PD, et al. (2015) Relating hippocampus to relational memory processing across domains and delays. J Cogn Neurosci 27, 234–245.
100.Monti JM, Hillman CH & Cohen NJ (2012) Aerobic fitness enhances relational memory in preadolescent children: the FITKids randomized control trial. Hippocampus 22, 1876–1882.
101.Kumaran D & Maguire EA (2009) Novelty signals: a window into hippocampal information processing. Trends Cogn Sci 13, 47–54.
102.Watson PD, Voss JL, Warren DE, et al. (2013) Spatial reconstruction by patients with hippocampal damage is dominated by relational memory errors. Hippocampus 23, 570–580.
103.Pertzov Y, Miller TD, Gorgoraptis N, et al. (2013) Binding deficits in memory following medial temporal lobe damage in patients with voltage-gated potassium channel complex antibody-associated limbic encephalitis. Brain 136, 2474–2485.
104.Hannula DE, Althoff RR, Warren DE, et al. (2010) Worth a glance: using eye movements to investigate the cognitive neuroscience of memory. Front Hum Neurosci 4, 166.
105.Wechsler D (2008) Wechsler Adult Intelligence Scale, 4th ed. San Antonio, TX: Pearson.
106.Daneman M & Carpenter PA (1980) Individual differences in working memory and reading. J Verbal Learn Verbal Behav 19, 450–466.
107.Conway AR, Kane MJ, Bunting MF, et al. (2005) Working memory span tasks: a methodological review and user’s guide. Psychonom Bull Rev 12, 769–786.
108.Harrison TL, Shipstead Z, Hicks KL, et al. (2013) Working memory training may increase working memory capacity but not fluid intelligence. Psychol Sci 24, 2409–2419.
109.de Jager CA, Dye L, de Bruin EA, et al. (2014) Criteria for validation and selection of cognitive tests for investigating the effects of foods and nutrients. Nutr Rev 72, 162–179.
110.Sizonenko SV, Babiloni C, Sijben JW, et al. (2013) Brain imaging and human nutrition: which measures to use in intervention studies? Adv Nutr 4, 554–556.
111.Walhovd KB, Storsve AB, Westlye LT, et al. (2014) Blood markers of fatty acids and vitamin D, cardiovascular measures, body mass index, and physical activity relate to longitudinal cortical thinning in normal aging. Neurobiol Aging 35, 1055–1064.
112.Smith AD, Smith SM, de Jager CA, et al. (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 5, e12244.
113.Douaud G, Refsum H, de Jager CA, et al. (2013) Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A 110, 9523–9528.
114.Jernerén F, Elshorbagy AK, Oulhaj A, et al. (2015) Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr 102, 215–221.
115.Peters A, Morrison JH, Rosene DL, et al. (1998) Feature article: are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex 8, 295–300.
116.Rapp PR & Gallagher M (1996) Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc Natl Acad Sci U S A 93, 9926–9930.
117.Gunning-Dixon FM, Brickman AM, Cheng JC, et al. (2009) Aging of cerebral white matter: a review of MRI findings. Int J Geriatr Psychiatry 24, 109–117.
118.Gunning-Dixon FM & Raz N (2000) The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 14, 224–232.
119.Sachdev P, Wen W, Chen X, et al. (2007) Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 68, 214–222.
120.Schmidt R, Schmidt H, Haybaeck J, et al. (2011) Heterogeneity in age-related white matter changes. Acta Neuropathol 122, 171–185.
121.Estruch R, Ros E, Salas-Salvadó J, et al. (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368, 1279–1290.
123.Gardener H, Scarmeas N, Gu Y, et al. (2012) Mediterranean diet and white matter hyperintensity volume in Northern Manhattan Study. Arch Neurol 69, 251–256.
124.Virtanen JK, Siscovick DS, Longstreth WT, et al. (2008) Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71, 439–446.
125.Virtanen JK, Siscovick DS, Lemaitre RN, et al. (2013) Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the Cardiovascular Health Study. J Am Heart Assoc 2, e000305.
126.Babb SM, Wald LL, Cohen BM, et al. (2002) Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology (Berl) 161, 248–254.
127.Minati L, Grisoli M & Bruzzone MG (2007) MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review. J Geriatr Psychiatry Neurol 20, 3–21.
128.Detre JA, Leigh JS, Williams DS, et al. (1992) Perfusion imaging. Magn Reson Med 23, 37–45.
129.Detre J, Rao H & Wang D (2012) Applications of arterial spin labeled MRI in the brain. J Mag Reson Imaging 35, 1026–1037.
130.Heo S, Prakash RS, Voss MW, et al. (2010) Resting hippocampal blood flow, spatial memory and aging. Brain Res 1315, 119–127.
131.Chapman SB, Aslan S, Spence JS, et al. (2013) Shorter term aerobic exercise improves brain, cognition, and cardiovascular fitness in aging. Front Aging Neurosci 5, 75.
132.Buxton R (2002) Introduction to Functional Magnetic Resonance Imaging: Principles and Techniques. New York: Cambridge University Press.
133.Raichle ME & Snyder AZ (2007) A default mode of brain function: a brief history of an evolving idea. NeuroImage 37, 1083–1090.
134.Buckner RL, Andrews-Hanna JR & Schacter DL (2008) The brain’s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124, 1–38.
135.Andrews-Hanna JR, Snyder AZ, Vincent JL, et al. (2007) Disruption of large-scale brain systems in advanced aging. Neuron 56, 924–935.
136.Voss MW, Prakash RS, Erickson KI, et al. (2010) Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front Aging Neurosci 2, 32.